PMFLIST Archives

July 2020

PMFLIST@LISTS.MICROBIOLOGYNETWORK.COM

Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Kyriaki Antoniou <[log in to unmask]>" <[log in to unmask]>
Reply To:
The Pharmaceutical Microbiology Forum Email List <[log in to unmask]>
Date:
Mon, 6 Jul 2020 07:58:36 +0000
Content-Type:
multipart/related
Parts/Attachments:
text/plain (4 kB) , image001.png (8 kB) , image002.png (8 kB) , image003.png (8 kB) , image004.png (8 kB) , image005.png (8 kB) , image012.jpg (4 kB) , image013.jpg (4 kB) , image014.png (47 kB)
Dear Forum,

Where microbial testing of a drug product is carried out, the method should be validated to confirm that the product does not influence the recovery of microorganisms. When the validation is completed, do we need to apply also periodic validation (e.g. once a year, every two years) to confirm that the method is still valid?




Best Regards

Kyriaki Antoniou

Microbiology Department Manager


Remedica Ltd

Tel.: +357 25-553000 | Direct Tel.: +357 25-553508 (Internal: 508) | Fax: +357 25-390192
Site address: Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus-EU
Mailing address:  Remedica Ltd, P.O. Box 51706, CY-3508, Limassol Cyprus-EU
Web: www.remedica.eu<http://www.remedica.eu/>

     [cid:image007.png@01D4FB72.4AE7DD60]
[cid:image008.png@01D4FB72.4AE7DD60] [cid:image009.png@01D31FE5.C193D820] <https://twitter.com/remedica?lang=en> [cid:image010.png@01D4FB72.4AE7DD60] [cid:image011.png@01D4FB72.4AE7DD60]
[EBA_OneToWatch_Ribbon_Horizontal][EBA_NationalWinner_Ribbon_Horizontal]
[cid:image014.png@01D65384.654A6090]
This e-mail, including any attachments is to be treated as confidential, is intended solely for the addressee and the information in it may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient of this communication (or have received this e-mail in error) a) please notify the sender immediately and delete this e-mail and any attachments from your system and b) you should not disclose the content of this e-mail or any attachments to any other person or use them in any way.


------------------
The PMFList is supported by our sponsors as a service to the scientific community.

Please take a second to visit our sponsors' web sites and say thank you for their support of this service.
If your company would be interested in sponsoring this community, please contact [log in to unmask]



Steris - http://www.sterislifesciences.com/

Charles River Laboratories - https://www2.criver.com/l/60962/2020-03-27/h6jqv6

Veltek Associates, Inc - http://www.sterile.com

Microbiologics, Inc. - http://www.microbiologics.com

BD Industrial Media - http://www.bd.com/ds/

Associates of Cape Cod, Inc. - http://www.acciusa.com/


=================================
The nature of this service is to provide a medium for communication.  The specific statements and endorsements of individuals participating in the discussions are not necessarily those of the PMF or the sponsors of the list.


ATOM RSS1 RSS2